ARQT - Arcutis Biotherapeutics, Inc.
IEX Last Trade
14.88
-0.100 -0.672%
Share volume: 55,897
Last Updated: Thu 26 Dec 2024 08:30:16 PM CET
Research and Development in Biotechnology (except Nanobiotechnology):
-0.11%
PREVIOUS CLOSE
CHG
CHG%
$14.98
-0.10
-0.67%
View ratios
| Fiscal Date | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | 2024-03-31 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | |
| Report Date | 2022-08-04 | 2022-11-08 | 2023-02-28 | 2023-05-09 | 2023-08-08 | 2023-11-03 | 2024-02-27 | 2024-05-14 | |
| Total revenue | 0.000 | 725.000 K | 2.961 M | 2.781 M | 5.190 M | 38.109 M | 13.526 M | 49.569 M | |
| Cost of revenue | 0.000 | 269.000 K | 485.000 K | 783.000 K | 776.000 K | 1.182 M | 2.246 M | 3.256 M | |
| Gross profit | 0.000 | 456.000 K | 2.476 M | 1.998 M | 4.414 M | 36.927 M | 11.280 M | 46.313 M | |
| inf% | 442.98% | -19.31% | 120.92% | 736.59% | -69.45% | 310.58% | |||
| Operating expenses | 65.827 M | 105.204 M | 70.900 M | 78.263 M | 71.177 M | 73.831 M | 72.449 M | 77.935 M | |
| Selling general and admin | 27.622 M | 35.473 M | 37.023 M | 42.918 M | 45.958 M | 47.595 M | 48.674 M | 54.794 M | |
| Research and development | 38.205 M | 69.731 M | 33.877 M | 35.345 M | 25.219 M | 26.236 M | 23.775 M | 23.141 M | |
| Total expenses | 65.827 M | 105.473 M | 71.385 M | 79.046 M | 71.953 M | 75.013 M | 74.695 M | 81.191 M | |
| 60.23% | -32.32% | 10.73% | -8.97% | 4.25% | -0.42% | 8.70% | |||
| Operating income | -65.827 M | -104.748 M | -68.424 M | -76.265 M | -66.763 M | -36.904 M | -61.169 M | -31.622 M | |
| Ebit | -65.827 M | -104.748 M | -68.424 M | -76.265 M | -66.763 M | -36.904 M | -61.169 M | -31.622 M | |
| Pretax income | -67.406 M | -107.709 M | -72.019 M | -80.100 M | -70.991 M | -41.742 M | -67.284 M | -35.058 M | |
| 59.79% | -33.14% | 11.22% | -11.37% | -41.20% | 61.19% | -47.90% | |||
| Income tax | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 3.023 M | 90.000 K | 324.000 K | |
| Net income basic | -67.406 M | -107.709 M | -72.019 M | -80.100 M | -70.991 M | -44.765 M | -66.284 M | -35.382 M | |
| -59.79% | 33.14% | -11.22% | 11.37% | 36.94% | -48.07% | 46.62% | |||
| Net income | -67.406 M | -107.709 M | -72.019 M | -80.100 M | -70.991 M | -44.765 M | -66.284 M | -35.382 M | |
| -59.79% | 33.14% | -11.22% | 11.37% | 36.94% | -48.07% | 46.62% |